Internal Medicine, Gastroenterology · Sun City, AZ
NPI
1881689792
Since 2005
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
13640 N 99th Ave, Ste 600
Sun City, AZ, 85351
Phone (623) 972-2116
Groups this clinician bills Medicare through
Medicare paid, 2024
$328K
11,848 services
Medicare patients, 2024
1,018
Average age 75
Drug cost, 2024
$1.4M
1,475 prescriptions
Company payments, 2025
$810
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Daryl S Hutchinson was code J3380 (injection, vedolizumab, intravenous, 1 mg), 4,500 times for 13 patients. In total Daryl S Hutchinson billed 11,848 services in 44 codes, and Medicare paid $328K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-02-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3380 Injection, vedolizumab, intravenous, 1 mg | Office | 4,500 | 13 | $17.37 | $78K |
| 99213 Office E&M - Established | Office | 465 | 385 | $66.17 | $31K |
| 45385 Colonoscopy - Lesion Removal | Facility | 214 | 213 | $200.37 | $43K |
| 99204 Office E&M - New | Office | 204 | 204 | $113.27 | $23K |
| 43239 Upper GI Endoscopy | Facility | 197 | 196 | $83.61 | $16K |
| 99203 Office E&M - New | Office | 169 | 169 | $67.94 | $11K |
| 45380 Lower GI Endoscopy - Other | Facility | 152 | 152 | $96.32 | $15K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 132 | 32 | $48.24 | $6,368 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 67 | 67 | $173.70 | $12K |
| 99214 Office E&M - Established | Office | 62 | 58 | $80.45 | $4,988 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 45 | 20 | $36.91 | $1,661 |
| 43235 Upper GI Endoscopy | Facility | 35 | 35 | $74.66 | $2,613 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 26 | 26 | $174.52 | $4,538 |
| 96365 Intravenous Infusion, Hydration | Office | 22 | 17 | $47.77 | $1,051 |
| 45378 Lower GI Endoscopy - Other | Facility | 20 | 20 | $135.76 | $2,715 |
By year: 2022 $321K for 14,090 services; 2023 $362K for 12,482 services; 2024 $328K for 11,848 services.
Medicare prescription drug claims, 2024
In 2024, the drug Daryl S Hutchinson prescribed most often to Medicare patients was Omeprazole, with 262 prescriptions and refills. In total Daryl S Hutchinson wrote 1,475 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 262 | 768 | 109 | $3,708 |
| Pantoprazole Sodium Generic | 240 | 697 | 99 | $4,322 |
| Famotidine Generic | 100 | 260 | 41 | $1,337 |
| Cholestyramine Cholestyramine (With Sugar) | 77 | 146 | 37 | $9,631 |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 60 | 70 | 24 | $2,339 |
| Linzess Linaclotide | 52 | 108 | 23 | $55K |
| Ondansetron Hcl Generic | 39 | 39 | 18 | $670 |
| Creon Lipase/Protease/Amylase | 33 | 56 | 12 | $148K |
| Dicyclomine Hcl Generic | 32 | 56 | 14 | $984 |
| Ondansetron Odt Ondansetron | 32 | 33 | 20 | $1,176 |
| Xifaxan Rifaximin | 31 | 31 | 12 | $91K |
| Budesonide Dr Budesonide | 31 | 65 | 11 | $4,337 |
| Mesalamine Generic | 26 | 69 | 11 | $6,870 |
| Esomeprazole Magnesium Generic | 19 | 57 | Under 11 | $676 |
| Ursodiol Generic | 18 | 44 | Under 11 | $2,811 |
Brand drugs: - claims; generic drugs: 1,207 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Daryl S Hutchinson $810 ($810 in general payments such as food, travel and fees) from 7 companies. The largest payer was Genzyme Corporation with $332.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.